Presentation of the project of the antitumor autoimmune vaccine commercialization30 September 2020р.
On September 15, the team of the Institute of Innovative Entrepreneurship of Kyiv National Economic University named after Vadym Hetman consisting of Viktoriia Kyrylenko and Yuliia Tereshchenko, 2nd year students of the "Project Management and Consulting" master's program and associate professor of business economics and entrepreneurship Liudmyla Petrenko presented Ukrainian case of commercialization of domestic innovation – antitumor autoimmune vaccine at the Krakow IP Law Summer School.
The IPSS Krakow (September 14-18) was organized by the Jagiellonian University (Poland) under the auspices of WIPO. IP Quality was the leitmotiv of this year's programme. The speakers and lecturers of the school are recognized experts in the field of intellectual property of both foreign and Polish universities, representatives of WIPO, EPO, EUIPO and other international organizations, as well as practitioners with experience in IP.
The case presented is part of a project of the antitumor autoimmune vaccine commercialization and related intellectual property rights. The project is carried out within the framework of cooperation between Kyiv National Economic University and the RE. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology NAS of Ukraine. The project is being developed by KNEU students Viktoriia Kyrylenko and Yuliia Tereshchenko under the guidance of research supervisor Liudmyla Petrenko.
This year, 9 representatives of KNEU took part in the Krakow IP Law Summer School, including 2 students and 7 professors of the Business Economics and Entrepreneurship Department.